BREAST CANCER THERAPY USING AN ENGINEERED RESPIRATORY SYNCYTIAL VIRUS
摘要
<p>The invention discloses an engineered oncolytic respiratory syncytial virus (RSV), NS l gene deficient RSV, and its usage to treat breast cancer by killing cancer cells with in vitro and in vivo evidences.</p>
